Financhill
Back

Travere Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

Travere Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Travere Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Travere Therapeutics, Inc. Stock

Is Travere Therapeutics, Inc. Stock a Buy?

TVTX Technical Analysis vs Fundamental Analysis

Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy or a Sell?

Travere Therapeutics, Inc. Stock Info

Market Cap:
3.6B
Price in USD:
40.2800
Share Volume:
3.8M

Travere Therapeutics, Inc. 52-Week Range

52-Week High:
37.5000
52-Week Low:
12.9100
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Travere Therapeutics, Inc. Share Price Forecast

Is Travere Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Travere Therapeutics, Inc.

Is Travere Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Technical Analysis of Travere Therapeutics, Inc.

Should I short Travere Therapeutics, Inc. stock?

* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.